Search clinical trials for: 30 mg anecortave acetate

Total 865 results

Alcon Research

Completed

A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration

AMD
Alcon Research

Completed

Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension

Open-angle Glaucoma | Oular Hypertension

United States
Alcon Research

Completed

Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)

Macular Degeneration

United States
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

AMD

United States
Alcon Research

Completed

Anecortave Acetate in Patients With Open-angle Glaucoma

Open-angle Glaucoma
Alcon Research

Completed

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

Eye Diseases

Spain, United States, Hungary, Brazil, Italy, Netherlands, Puerto Rico, United Kingdom
Alcon Research

Terminated

Anecortave Acetate Risk Reduction Trial (AART)

AMD

India
Cornea Research Foundation of America

Terminated

Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients

Intraocular Pressure | Transplant

United States
Alcon Research

Completed

Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

Open-angle Glaucoma

United States
Alcon Research

Terminated

Anecortave Acetate Risk-Reduction Trial (AART)

Dry AMD

United States
Alcon Research

Terminated

A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Terminated

Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

Macular Degeneration

United States
Alcon Research

Completed

Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

Macular Degeneration | Age-Related Maculopathies | Age-Related Maculopathy | Maculopathies, Age-Related | Maculopathy, Age-Related
Manhattan Eye, Ear & Throat Hospital
Alcon Research; LuEsther T. Mertz Retinal Research Center

Completed

Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate (CSC-AA)

Chronic Central Serous Chorioretinopathy

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Eye Diseases | Pseudovitellium Detachment

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Diabetic Retinopathy

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration

United States
Ambrilia Biopharma, Inc.

Completed

Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients

Acromegaly

Belarus, Hungary, Romania, Serbia, Slovakia, Ukraine
Alcon Research

Completed

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Macular Degeneration

United States
Federal University of São Paulo
Alcon Research

Unknown

IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients

Glaucoma | Intraocular Pressure

Brazil
Alcon Research

Completed

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

Macular Degeneration | Maculopathy, Age-Related

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)

Coat's Disease

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Idiopathic Perifoveal Telangiectasia (IPT) With Open-Label Anecortave Acetate (15mg.).

Idiopathic Perifoveal Telangiectasia

United States
Alcon Research

Completed

Anecortave Acetate Versus Placebo in AMD Patients Following PDT

AMD

United States
Alcon Research

Withdrawn

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Open-Angle Glaucoma
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Central Retinal Vein Occlusion | Severe Diabetic Retinopathy | Chronic Inflammation | Infectious Diseases

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Age-Related Macular Degenerations. | Subfoveal Neovascularization.

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Completed

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Maculopathy, Age-Related

United States
University of Iowa

No longer available

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Withdrawn

Treatment of Retinal Vein Occlusion (RVO) With Open-Label Anecortave Acetate (15mg.)

Retinal Vein Occlusion

United States
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Radiation Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

Eye Injuries

United States
Texas Retina Associates
Alcon Research

Completed

Prophylactic Anecortave Acetate in Patients With a Retisert Implant

Glaucoma | Uveitis, Posterior

United States
Azidus Brasil

Suspended

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Acromegaly

Brazil
Repros Therapeutics Inc.

Completed

Extension of Study ZPV-200

Uterine Fibroids

United States
Abbott

Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Puberty, Precocious

United States, Puerto Rico
Donesta Bioscience

Completed

Effect of Food on the Bioavailability of 30 mg Estetrol (E4) Tablet in Healthy Postmenopausal Female Volunteers

Food-effect

Bulgaria
Fondazione Oncotech

Not yet recruiting

NEOadjuvant Abemaciclib and GIredestrant triaL in Patients With ER-positive, HER2-negative Early Breast Cancer (Neo-AGILE)

Breast Cancer

Italy
Regeneron Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants

Respiratory Syncytial Virus Infections

United States, Australia, Bulgaria, Canada, Chile, Denmark, Finland, Germany, Hungary, Netherlands, New Zealand, Panama, Puerto Rico, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom
Cerevel Therapeutics, LLC

Completed

Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants

Schizophrenia

United States
Galderma R&D

Completed

An Efficacy and Safety Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis

Prurigo Nodularis

United States, Germany, Austria, Canada, Denmark, Hungary, Italy, Poland, Sweden, United Kingdom
Pfizer

Completed

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers

Hepatic Impairment | Healthy Participants

United States
Otsuka Pharmaceutical Development & Commercialization...
Bill and Melinda Gates Foundation

Completed

A Phase 1/2 Trial of Multiple Oral Doses of OPC-167832 for Uncomplicated Pulmonary Tuberculosis

Pulmonary TB

South Africa
Allergan

Completed

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

Chronic Migraine

United States, Australia, Canada, China, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Sweden, Taiwan, United Kingdom
HRA Pharma

Completed

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions (LIBRella)

Emergency Contraception

United States
Vigonvita Life Sciences

Completed

Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers

Healthy Subjects

China
Novartis Pharmaceuticals

Completed

Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly

Acromegaly

Italy
Merck Sharp & Dohme LLC

Terminated

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Anemia | Bladder Cancer | Cancer of Head and Neck | Uterine Cervical Cancer | Carcinoma, Small-Cell Lung
GlaxoSmithKline

Completed

A New Oral Treatment For Type II Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, Germany, Canada, Sweden, Latvia, Finland, Greece, Romania, Czechia, Puerto Rico
MedImmune LLC

Completed

A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults

Asthma

United States, Canada, Peru, Taiwan, Colombia, Brazil, Panama, Philippines, Argentina, Costa Rica
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Solid Formulations of JNJ-39393406 in Healthy Male Participants

Healthy

Belgium

Search clinical trials for: 30 mg anecortave acetate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations